Injection Pen Market Size, Share & Trends Analysis Report By Form, By Application, By Region And Segment Forecasts, 2020 – 2028

(Heraldkeepers via Comtex)

The Injection Pen Market is expected to exceed more than US$ 41 Billion by 2024 at a CAGR of 6% in the given forecast period.

Browse Full Report:

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Merck & Company Inc., Novartis AG, Eli Lilly and Company, Hoffmann-La Roche AG, Novo Nordisk A/S, Dickinson and Company, Becton, Sanofi SA, Pfizer Inc., Ypsomed and Astrazeneca plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Injection pens are wide used in varied therapeutic applications such diabetes, osteoporosis because it provides varied benefits over the normal vial-and-syringe methodology. for example, insulin pen devices improve patient satisfaction and adherence. what is more, it’s simple to use and provides accuracy in delivering little dose of insulin. additionally, injection pen is user friendly, the little needle sizes cut back worry and pain and therefore has larger social acceptability. Injection pen is wide employed in diabetic patients.

The scope of the report includes a detailed study of Injection Pen Marketwith the reasons given for variations in the growth of the industry in certain regions.

The Injection Pen Market has been segmented as below:

The Injection Pen Market is Segmented on the lines of Type, Therapy, End-User and Regional Analysis.By Type this market is segmented on the basis ofDisposable injection pens and Reusable injection pens. By Therapy this market is segmented on the basis ofDiabetes, Growth hormone therapy, Fertility and Osteoporosis.

By End-User this market is segmented on the basis ofHome care sector and Hospital & clinics sector. By Regional Analysis this market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Injection Pen Marketand related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Injection Pen Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Injection Pen Market are as follows:

Growing Prevalence of Chronic DiseasesIncreasing range of restrictive ApprovalsFavourable compensation and Government Support

The major restraining factors of Injection Pen Market are as follows:

Preference for various Drug Delivery ModesPoor reimbursement scenario in Developing Countries

Request Sample Report @:

Table of Contents

IntroductionResearch Methodology

2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions

Summary with InsightsMarket OverviewInjection Pen Market Analysis, By ProductInjection Pen Market Analysis, By End-UserInjection Pen Market Analysis, By TherapyInjection Pen Market Analysis, By RegionCompetitive OverviewCompany Profiles

10.1 Novo Nordisk A/S

10.2 Astrazeneca plc

10.3 Eli Lilly and Company

10.4 Merck & Company, Inc.

10.5 Sanofi SA

10.6 Novartis AG

10.7 Pfizer Inc.

10.8 Becton, Dickinson and Company

10.9 Hoffmann-La Roche AG

10.10 Ypsomed

Other Related Market News :

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States


Source - HeraldKeeper
Note: The Heraldkeeper News Department was not involved in the creation of this content.

If you have any problem with this press release? Contact the source provider, you can contact them here. comtex tracking